Was the Clearfield (CLFD) CEO’s share sale under a Rule 10b5-1 plan?

Yes. A footnote explains the transaction was effected under a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025 . Such plans schedule trades in advance, helping separate them from day-to-day market timing decisions.

Planned share sale by Clearfield (CLFD) CEO under 10b5-1 plan

Q: How many Clearfield (CLFD) shares does the CEO hold after this sale?

After the reported sale, CEO Cheryl Beranek directly holds 502,041 Clearfield shares . This indicates the 2,500 shares sold represent a small fraction of her overall direct ownership position in the company’s Common Stock.

Q: What type of transaction did the Clearfield (CLFD) Form 4 disclose?

The Form 4 discloses an open-market sale of Common Stock, coded “S” for sale. It involves 2,500 shares sold at $50.00 per share, with the CEO’s remaining direct holdings reported at 502,041 shares afterward.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Clearfield, Inc. Chief Executive Officer Cheryl Beranek reported an open-market sale of 2,500 shares of the company’s Common Stock at $50.00 per share on May 27, 2026. After this transaction, she directly holds 502,041 shares. The footnote states the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 15, 2025, indicating it was scheduled in advance as part of a trading program.

Insider Trade Summary 10b5-1

Net Seller: 2,500 shares ($125,000)

Net Sell 1 txn

Insider Beranek Cheryl

Role Chief Executive Officer

Sold 2,500 shs ($125K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,500	$50.00	$125K

Holdings After Transaction: Common Stock — 502,041 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares sold: 2,500 shares Sale price: $50.00 per share Post-transaction holdings: 502,041 shares +2 more

5 metrics

Shares sold 2,500 shares Open-market sale on May 27, 2026

Sale price $50.00 per share Price for the 2,500 shares sold

Post-transaction holdings 502,041 shares Direct ownership after sale

Transaction code S (sale) Open-market or private sale of non-derivative shares

Trading plan adoption date December 15, 2025 Rule 10b5-1 plan referenced in footnote

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"The transaction reported on this form was effected to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/28/2026 - 05:21 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beranek Cheryl

(Last)

(First)

(Middle)

7050 WINNETKA AVE. N.

SUITE 100

(Street)

BROOKLYN PARK

MINNESOTA

55428

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clearfield, Inc. [ CLFD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/27/2026		S⁽¹⁾		2,500	D	$50	502,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transaction reported on this form was effected to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025.

	Darrell Hammond by Power of Attorney for Cheryl Beranek	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Clearfield (CLFD) report for its CEO?

Clearfield reported that CEO Cheryl Beranek sold 2,500 shares of Common Stock. The shares were sold in an open-market transaction at $50.00 per share, and the trade was executed under a pre-arranged Rule 10b5-1 trading plan.

How many Clearfield (CLFD) shares does the CEO hold after this sale?

After the reported sale, CEO Cheryl Beranek directly holds 502,041 Clearfield shares. This indicates the 2,500 shares sold represent a small fraction of her overall direct ownership position in the company’s Common Stock.

At what price did the Clearfield (CLFD) CEO sell her shares?

The CEO’s 2,500 Clearfield shares were sold at an average price of $50.00 per share. This price reflects the execution level disclosed for the open-market transaction on the Form 4 insider trading report.

What type of transaction did the Clearfield (CLFD) Form 4 disclose?

The Form 4 discloses an open-market sale of Common Stock, coded “S” for sale. It involves 2,500 shares sold at $50.00 per share, with the CEO’s remaining direct holdings reported at 502,041 shares afterward.